OpenAlex
PricingAboutJobs
Log inGet started
Work

A Short Treatment With an Antibody to Sclerostin Can Inhibit Bone Loss in an Ongoing Model of Colitis

HTML

Year: 2009
Type: article
Source: Journal of Bone and Mineral Research
DOI: 10.1359/jbmr.090403
Authors: Alison Eddleston, Massimo Marenzana, Adrian R Moore, Paul Stephens, Mariusz Muzylak, Diane Marshall, Martyn K Robinson
Institution: UCB Pharma (United Kingdom)
Language: English

Topic: Bone health and osteoporosis research
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: sclerostin, neutralizing antibodies, colitis, bone loss, chronic inflammation, bone mineral density, osteoblast activity, osteoclast resorption, bone formation markers, inflammatory bone disease, mouse model
SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, UCB Pharma
OpenAlex ID: W2029361003
FWCI: 13.71
Cites: 38
Cited by: 101
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security